Consensus Handa Pharmaceuticals, Inc.

Equities

6620

TW0006620008

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
140.5 ^TWD	+1.08%		+16.12%	-23.43%

Apr. 02	Handa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Handa Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Evolution of the average Target Price on Handa Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

91dd54393531c431a8d9e517b.-KYdcPZW_BOfg79r1wlDYPuRkRIBlHelMlSqyWRHNPM.uchcRJsUqVH-291f4msADKH713Zy4hvfATDYp1UTY5mK8144ni_PYvC66g~f65b0974838a418deb0b89db955a71d7

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

140.5 TWD

Average target price

200 TWD

Spread / Average Target

+42.35%

High Price Target

200 TWD

Spread / Highest target

+42.35%

Low Price Target

200 TWD

Spread / Lowest Target

+42.35%

Consensus detail

Consensus revision (last 18 months)

Ratings for Handa Pharmaceuticals, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar